![](/img/cover-not-exists.png)
A COMPARISON OF HUMANIZED MONOCLONAL ANTIBODY (BASILIXIMAB) INDUCTION THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS.
Falkenstein, Kathleen P., Casas, Adela T., Flynn, Louise M., Kirkpatrick, Beverly S., Dunn, Stephen P.Volume:
69
Journal:
Transplantation
DOI:
10.1097/00007890-200004271-00220
Date:
April, 2000
File:
PDF, 1.70 MB
2000